Royce & Associates LP

SEC CIK: 0000906304
Latest filing: Aug 14, 2026

SEC filings (opens in a new tab)

INDV holding history

Indivior Pharmaceuticals, Inc. in every 13F filed by Royce & Associates LP, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

INDV overview All 13F holders of INDV Full Q2 2026 holdings

Shares (Q2 2026): 0; Sold out in Q2 2026
Value: $0
% of portfolio: 0.0%
Quarters held: 3; Since Q3 2025

Holdings of INDV by Royce & Associates LP, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q2 2026	0	$0	0.0%	−9,900−100.0%	Sold out	Holders
Q1 2026	9,900	$301.8K	<0.1%	−297,957−96.8%	Reduced	Holders
Q4 2025	307,857	$11.0M	0.1%	+61,333+24.9%	Added	Holders
Q3 2025	246,524	$5.94M	0.1%	+246,524	New	Holders